Arrayit Corporation (OTCMKTS: ARYC) is a California‐based life sciences company specializing in the design, development and manufacture of advanced microarray and laboratory automation systems. The company’s core competency lies in its proprietary biochip platform, which enables high‐throughput analysis of genes, proteins and other biomolecules. Arrayit’s solutions are used by academic institutions, pharmaceutical and biotechnology firms, as well as diagnostic laboratories seeking to accelerate research and streamline workflows.
At the heart of Arrayit’s product line is its microarray technology, featuring glass and polymer‐based chips that support applications in genomics, proteomics and biomarker discovery. Complementing these biochips are automated slide processors, hybridization stations and microarray scanners engineered for precision and reproducibility. The company also offers a range of assay kits, reagents and software tools designed to facilitate data collection, image analysis and result interpretation, enabling researchers to extract meaningful insights from complex biological samples.
Arrayit serves a diverse customer base across North America, Europe and Asia, maintaining a network of authorized distributors and direct sales specialists to support scientific and technical needs. Its systems have been deployed in research centers focused on cancer, immunology, infectious diseases and personalized medicine, where rapid biomarker screening and multi‐analyte analysis are critical. Through collaborative partnerships with universities and contract research organizations, Arrayit continues to refine its platform for emerging applications in diagnostics and drug development.
Founded in the late 1990s and headquartered in Sunnyvale, California, Arrayit was established by a team of molecular biologists and engineers with a shared vision of transforming laboratory workflows. Under the leadership of its CEO, a veteran of molecular diagnostics, the company has expanded its product portfolio while maintaining an emphasis on quality management and regulatory compliance. Moving forward, Arrayit aims to bolster its global footprint and invest in next‐generation array and automation technologies to meet the evolving demands of life sciences research and clinical testing.
AI Generated. May Contain Errors.
Free ARYC Stock Alerts